These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18837790)

  • 1. Understanding the contribution of cellular immunity to dengue disease pathogenesis.
    Mathew A; Rothman AL
    Immunol Rev; 2008 Oct; 225():300-13. PubMed ID: 18837790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection.
    Elong Ngono A; Chen HW; Tang WW; Joo Y; King K; Weiskopf D; Sidney J; Sette A; Shresta S
    EBioMedicine; 2016 Nov; 13():284-293. PubMed ID: 27746192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes.
    Imrie A; Meeks J; Gurary A; Sukhbataar M; Kitsutani P; Effler P; Zhao Z
    J Virol; 2007 Sep; 81(18):10081-91. PubMed ID: 17626101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.
    Zellweger RM; Tang WW; Eddy WE; King K; Sanchez MC; Shresta S
    J Virol; 2015 Jun; 89(12):6494-505. PubMed ID: 25855749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.
    Zompi S; Santich BH; Beatty PR; Harris E
    J Immunol; 2012 Jan; 188(1):404-16. PubMed ID: 22131327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.
    Mongkolsapaya J; Dejnirattisai W; Xu XN; Vasanawathana S; Tangthawornchaikul N; Chairunsri A; Sawasdivorn S; Duangchinda T; Dong T; Rowland-Jones S; Yenchitsomanus PT; McMichael A; Malasit P; Screaton G
    Nat Med; 2003 Jul; 9(7):921-7. PubMed ID: 12808447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.
    Kitab B; Kohara M; Tsukiyama-Kohara K
    Arch Virol; 2018 Jul; 163(7):1717-1726. PubMed ID: 29520688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil Activation and Early Features of NET Formation Are Associated With Dengue Virus Infection in Human.
    Opasawatchai A; Amornsupawat P; Jiravejchakul N; Chan-In W; Spoerk NJ; Manopwisedjaroen K; Singhasivanon P; Yingtaweesak T; Suraamornkul S; Mongkolsapaya J; Sakuntabhai A; Matangkasombut P; Loison F
    Front Immunol; 2018; 9():3007. PubMed ID: 30687301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
    Lau L; Green AM; Balmaseda A; Harris E
    J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Heterotypic DENV-specific CD8
    Talarico LB; Batalle JP; Byrne AB; Brahamian JM; Ferretti A; García AG; Mauri A; Simonetto C; Hijano DR; Lawrence A; Acosta PL; Caballero MT; Paredes Rojas Y; Ibañez LI; Melendi GA; Rey FA; Damonte EB; Harris E; Polack FP
    EBioMedicine; 2017 Jun; 20():202-216. PubMed ID: 28483582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of cellular immune responses in the acute phase of dengue virus infection.
    Yoshida T; Omatsu T; Saito A; Katakai Y; Iwasaki Y; Kurosawa T; Hamano M; Higashino A; Nakamura S; Takasaki T; Yasutomi Y; Kurane I; Akari H
    Arch Virol; 2013 Jun; 158(6):1209-20. PubMed ID: 23381396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated cytokine storm and its role in severe dengue.
    Srikiatkhachorn A; Mathew A; Rothman AL
    Semin Immunopathol; 2017 Jul; 39(5):563-574. PubMed ID: 28401256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to dengue virus and prospects for a vaccine.
    Murphy BR; Whitehead SS
    Annu Rev Immunol; 2011; 29():587-619. PubMed ID: 21219187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress towards understanding the pathogenesis of dengue hemorrhagic fever.
    Pang X; Zhang R; Cheng G
    Virol Sin; 2017 Feb; 32(1):16-22. PubMed ID: 27853992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner.
    Beaumier CM; Mathew A; Bashyam HS; Rothman AL
    J Infect Dis; 2008 Feb; 197(4):608-17. PubMed ID: 18275279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges for the formulation of a universal vaccine against dengue.
    Chokephaibulkit K; Perng GC
    Exp Biol Med (Maywood); 2013 May; 238(5):566-78. PubMed ID: 23856907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate.
    Chen HR; Lai YC; Yeh TM
    J Biomed Sci; 2018 Jul; 25(1):58. PubMed ID: 30037331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis.
    Rothman AL
    Curr Top Microbiol Immunol; 2010; 338():83-98. PubMed ID: 19802580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Autoimmune Mechanism in Dengue Hemorrhagic Fever.
    Lardo S; Soesatyo MH; Juffrie J; Umniyati SR
    Acta Med Indones; 2018 Jan; 50(1):70-79. PubMed ID: 29686179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intact signal peptide on dengue virus E protein enhances immunogenicity for CD8(+) T cells and antibody when expressed from modified vaccinia Ankara.
    Quinan BR; Flesch IE; Pinho TM; Coelho FM; Tscharke DC; da Fonseca FG
    Vaccine; 2014 May; 32(25):2972-9. PubMed ID: 24726244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.